APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells. - Mohell N; Alfredsson J; Fransson Å; Uustalu M; Byström S; Gullbo J; Hallberg A; Bykov VJ; Björklund U; Wiman KG (Cell death & disease, 2015)